Condition: Alcohol Use Disorder · Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Patients with hepatic steatosis due to alcohol will be offered liver biopsies when they enter a detoxification program. The first biopsy will occur in the first week of admission and the second in the fourth week when the steatosis has resolved. The hepatic transcriptome will be compared,
This description comes directly from the study's public registry record.
Sawsan Fathma, M.D. · (301) 451-1273 · sawsan.fathma@nih.gov
Theo Heller, M.D. · (301) 402-7147 · theoh@intra.niddk.nih.gov
Always discuss trial participation with your own doctor first.
| National Institutes of Health Clinical Center | Bethesda, Maryland, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07191561